NathanJRobisonMD
Pediatric Hematology & Oncology • Los Angeles, CAPediatric Neuro-Oncology
Assistant Professor
Dr. Robison is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4650 W Sunset Blvd
Los Angeles, CA 90027Phone+1 888-631-2452Fax+1 323-361-8988- Is this information wrong?
Education & Training
Brigham and Women's Hospital/Dana-Farber Cancer Institute/Harvard Medical SchoolFellowship, Pediatric Neuro-Oncology, 2009 - 2010
Children's Hospital Los AngelesFellowship, Pediatric Hematology/Oncology, 2006 - 2009- Children's Hospital Los AngelesResidency, Pediatrics, 2002 - 2005
Keck School of Medicine of the University of Southern CaliforniaClass of 2002
Certifications & Licensure
CA State Medical License 2004 - 2026
MA State Medical License 2009 - 2014- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG) Start of enrollment: 2011 Sep 01
- MEK Inhibitor PD-0325901 Trial in Adolescents and Adults With NF1 Start of enrollment: 2014 Jun 01
- A Trial of Dabrafenib, Trametinib and Hydroxychloroquine for Patients With Recurrent LGG or HGG With a BRAF Aberration Start of enrollment: 2020 Jan 17
Roles: Contact, Principal Investigator
- Join now to see all
Publications & Presentations
PubMed
- Consensus framework for conducting phase I/II clinical trials for children, adolescents, and young adults with pediatric low-grade glioma: Guidelines established by th...Sabine Mueller, Jason Fangusaro, Arzu Onar Thomas, Thomas S Jacques, Pratiti Bandopadhayay, Peter de Blank, Roger J Packer, Maryam Fouladi, Antoinette Schouten van Mee...> ;Neuro-Oncology. 2024 Mar 4
- An Exome Capture-Based RNA-Sequencing Assay for Genome-Wide Identification and Prioritization of Clinically Important Fusions in Pediatric Tumors.Buckley, J., Schmidt, R., Ostrow, D., Maglinte, D., Bootwalla, M., Ruble, D., Govindarajan, A., Ji, J., Kovach, A., Orgel, E., Raca, G., Navid, F., Mascarenhas, L., Pa...> ;The Journal of Molecular Diagnostics. 2024 Feb 1
- Addendum: Sustained response of three pediatric BRAFV600E mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy.Stephanie A Toll, Hung N Tran, Jennifer Cotter, Alexander R Judkins, Benita Tamrazi, Jaclyn A Biegel, Girish Dhall, Nathan J Robison, Kaaren Waters, Palak Patel, Rober...> ;Oncotarget. 2023 May 19
- Join now to see all
Press Mentions
Gateway for Cancer Research Announces Completion of Phase I Clinical Trial Using “Tumor Paint” in Pediatric Brain Cancer SurgeryApril 24th, 2018
Hospital Affiliations
Children's Hospital Los AngelesLos Angeles, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
